We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01424436
First Posted: August 29, 2011
Last Update Posted: June 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
GlaxoSmithKline